title: The SU.VI.MAX trial on antioxidants.
authors.affiliation: U557 INSERM/U1125 INRA, ISTNA-CNAM, 5, rue Vertbois, 75003 Paris, France.
authors.forename: S
authors.initials: S
authors.lastname: Hercberg
authors.forename: P
authors.initials: P
authors.lastname: Galan
authors.forename: P
authors.initials: P
authors.lastname: Preziosi
authors.forename: M
authors.initials: M
authors.lastname: Malvy
authors.forename: S
authors.initials: S
authors.lastname: Briançon
authors.forename: Hadad M
authors.initials: HM
authors.lastname: Ait
authors.forename: B
authors.initials: B
authors.lastname: Rahim
authors.forename: A
authors.initials: A
authors.lastname: Favier
mesh_terms: D000328:Adult; D000975:Antioxidants / Q000008:administration & dosage* / Q000627:therapeutic use; D002908:Chronic Disease; D015331:Cohort Studies; D019587:Dietary Supplements; D004311:Double-Blind Method; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D015994:Incidence; D008137:Longitudinal Studies; D008297:Male; D008875:Middle Aged; D008903:Minerals / Q000008:administration & dosage* / Q000627:therapeutic use; D017202:Myocardial Ischemia / Q000453:epidemiology / Q000401:mortality / Q000517:prevention & control*; D009369:Neoplasms / Q000453:epidemiology / Q000401:mortality / Q000517:prevention & control*; D009752:Nutritional Status; D011322:Primary Prevention; D016896:Treatment Outcome; D014815:Vitamins / Q000008:administration & dosage* / Q000627:therapeutic use
chemical_list: D000975:Antioxidants; D008903:Minerals; D014815:Vitamins